PMGC HOLDINGS INC. Financing Cash Flow
PMGC HOLDINGS INC. (ELAB) reported Financing Cash Flow of $23.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- PMGC HOLDINGS INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $9.46M, a 544.60% increase year-over-year.
- PMGC HOLDINGS INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $14.41M, a 389.70% increase year-over-year.
- PMGC HOLDINGS INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$1.00.
- PMGC HOLDINGS INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $5.71M.
- PMGC HOLDINGS INC. net cash provided by (used in) financing activities for fiscal 2025 was $10.12M, a 49.71% increase from fiscal 2024.
- PMGC HOLDINGS INC. net cash provided by (used in) financing activities for fiscal 2024 was $6.76M, a 0.28% increase from fiscal 2023.
- PMGC HOLDINGS INC. net cash provided by (used in) financing activities for fiscal 2023 was $6.74M, a 185.27% increase from fiscal 2022.
- PMGC HOLDINGS INC. net cash provided by (used in) financing activities for fiscal 2022 was $2.36M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $9.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $23.87M 10-Q · filed 2026-08-14 | $23.87M derived: sum of 3 quarters · filed 2026-08-14 | $29.58M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $14.41M 10-Q · filed 2026-05-15 | $14.41M derived: sum of 2 quarters · filed 2026-05-15 | $20.12M derived: sum of 3 quarters · filed 2026-05-15 | $21.59M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $5.71M derived: sum of 2 quarters · filed 2026-03-30 | $7.17M derived: sum of 3 quarters · filed 2026-08-14 | $10.12M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $5.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $7.17M derived: sum of 2 quarters · filed 2026-08-14 | $10.12M 10-Q · filed 2025-11-14 | $10.12M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $4.41M 10-Q · filed 2026-08-14 | $4.41M derived: sum of 3 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $2.94M 10-Q · filed 2026-05-15 | $2.94M derived: sum of 2 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $6.76M 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $6.76M 10-Q · filed 2025-11-14 | ||||
| 2023-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $5.63M derived: sum of 2 quarters · filed 2025-03-28 | $5.95M derived: sum of 3 quarters · filed 2025-03-28 | $6.74M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $390.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $713.59K derived: sum of 2 quarters · filed 2024-11-14 | $1.50M 10-Q · filed 2024-11-14 | $1.50B 10-Q · filed 2023-12-11 | -$2.27B derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $323.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.11M 10-Q · filed 2024-08-14 | -$2.27B derived: sum of 3 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $787.50K 10-Q · filed 2024-05-15 | -$2.27B derived: sum of 2 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$2.27B derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $2.36M 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $2.28B 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |